Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.

Germar K, Fehres CM, Scherer HU, van Uden N, Pollastro S, Yeremenko N, Hansson M, Kerkman PF, van der Voort EIH, Reed E, Maassen H, Kwakkenbos MJ, Bakker AQ, Klareskog L, Malmström V, de Vries N, Toes REM, Lundberg K, Spits H, Baeten DL.

Arthritis Rheumatol. 2019 Mar;71(3):340-350. doi: 10.1002/art.40739. Epub 2019 Feb 2.

PMID:
30277007
2.

B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation.

Vergroesen RD, Slot LM, Hafkenscheid L, Koning MT, van der Voort EIH, Grooff CA, Zervakis G, Veelken H, Huizinga TWJ, Rispens T, Scherer HU, Toes REM.

Ann Rheum Dis. 2018 Jun;77(6):956-958. doi: 10.1136/annrheumdis-2017-212052. Epub 2017 Aug 23. No abstract available.

PMID:
28835463
3.

Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).

van der Voort EAM, Wakkee M, Veldt-Kok P, Darwish Murad S, Nijsten T.

Br J Dermatol. 2017 Jun;176(6):1599-1606. doi: 10.1111/bjd.15220. Epub 2017 Apr 24.

PMID:
27925155
4.

Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies.

Kerkman PF, Kempers AC, van der Voort EI, van Oosterhout M, Huizinga TW, Toes RE, Scherer HU.

Ann Rheum Dis. 2016 Dec;75(12):2201-2207. doi: 10.1136/annrheumdis-2015-208554. Epub 2016 Apr 11.

PMID:
27069015
5.

Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study.

van der Voort EA, Koehler EM, Nijsten T, Stricker BH, Hofman A, Janssen HL, Schouten JN, Wakkee M.

Acta Derm Venereol. 2016 Feb;96(2):213-7. doi: 10.2340/00015555-2161.

6.

Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.

Kerkman PF, Fabre E, van der Voort EI, Zaldumbide A, Rombouts Y, Rispens T, Wolbink G, Hoeben RC, Spits H, Baeten DL, Huizinga TW, Toes RE, Scherer HU.

Ann Rheum Dis. 2016 Jun;75(6):1170-6. doi: 10.1136/annrheumdis-2014-207182. Epub 2015 Jun 1.

PMID:
26034045
7.

Acrylate-induced nail contact allergy.

van der Voort EA, van Neer FJ, Neumann HA.

Int J Dermatol. 2014 Sep;53(9):e390-2. doi: 10.1111/ijd.12378. Epub 2014 Jun 5. No abstract available.

PMID:
24898035
8.

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.

van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, Schouten JN, Nijsten T.

J Am Acad Dermatol. 2014 Mar;70(3):517-24. doi: 10.1016/j.jaad.2013.10.044. Epub 2013 Dec 24.

PMID:
24373781
9.

Retraction for Schuerwegh et al., Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345. doi: 10.1073/pnas.1320459110. Epub 2013 Nov 25. No abstract available.

10.

Proximal fractures of the humerus in patients older than 75 years of age: should we consider operative treatment?

de Kruijf M, Vroemen JP, de Leur K, van der Voort EA, Vos DI, Van der Laan L.

J Orthop Traumatol. 2014 Jun;15(2):111-5.

11.

Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis.

Kerkman PF, Rombouts Y, van der Voort EI, Trouw LA, Huizinga TW, Toes RE, Scherer HU.

Ann Rheum Dis. 2013 Jul;72(7):1259-63. doi: 10.1136/annrheumdis-2012-202893. Epub 2013 Apr 26.

PMID:
23625975
12.

Netherton syndrome with multiple non-melanoma skin cancers.

van der Voort EA, Prens EP.

Acta Derm Venereol. 2013 Nov;93(6):727-8. doi: 10.2340/00015555-1558. No abstract available.

13.

Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis.

Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T.

Br J Dermatol. 2013 Aug;169(2):266-82. doi: 10.1111/bjd.12355. Review.

PMID:
23550658
14.

A giant aneurysm of the popliteal vein.

van der Voort EA, De Maeseneer MG.

Vasa. 2012 May;41(3):229-32. doi: 10.1024/0301-1526/a000191. Review.

PMID:
22565626
15.

World Federation of Pediatric Intensive Care and Critical Care Societies: Global Sepsis Initiative.

Kissoon N, Carcillo JA, Espinosa V, Argent A, Devictor D, Madden M, Singhi S, van der Voort E, Latour J; Global Sepsis Initiative Vanguard Center Contributors.

Pediatr Crit Care Med. 2011 Sep;12(5):494-503. doi: 10.1097/PCC.0b013e318207096c.

PMID:
21897156
16.

DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4.

Han WG, van der Voort EI, el Bannoudi H, Louis-Plence P, Huizinga TW, Toes RE.

Eur J Immunol. 2010 Oct;40(10):2731-40. doi: 10.1002/eji.201040574.

17.

The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.

van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP, van der Helm-van Mil AH, van der Heijde DM, Huizinga TW, Kvien TK, Toes RE.

Ann Rheum Dis. 2010 Jun;69(6):1110-6. doi: 10.1136/ard.2009.116384. Epub 2010 May 3.

PMID:
20439289
18.

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjée AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2586-91. doi: 10.1073/pnas.0913054107. Epub 2010 Jan 25. Retraction in: Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345.

19.

Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.

Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A.

Arthritis Rheum. 2010 Jan;62(1):117-25. doi: 10.1002/art.25059.

20.

[A man with a nail defect of the middle finger].

van der Voort EA, Erceg A.

Ned Tijdschr Geneeskd. 2009;153:B132. Dutch.

PMID:
19900334
21.

World Federation of Pediatric Intensive and Critical Care Societies-its global agenda.

Kissoon N, Argent A, Devictor D, Madden MA, Singhi S, van der Voort E, Latour JM.

Pediatr Crit Care Med. 2009 Sep;10(5):597-600. doi: 10.1097/PCC.0b013e3181a704c6.

PMID:
19451845
22.

Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.

Damjanovska L, Thabet MM, Levarth EW, Stoeken-Rijsbergen G, van der Voort EI, Toes RE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2010 Apr;69(4):730-2. doi: 10.1136/ard.2009.108456. Epub 2009 May 17.

PMID:
19451136
23.

[Focal epithelial hyperplasia of the oral mucosa. A unique manifestation of human papillomavirus].

van der Voort EA, Arani SF, Hegt VN, van Praag MC.

Ned Tijdschr Tandheelkd. 2009 Mar;116(3):149-51. Dutch.

PMID:
19382543
24.

Assessment of withdrawal symptoms in pediatric intensive care patients, a new future?

Ista E, van der Voort E.

Pediatr Crit Care Med. 2008 Nov;9(6):654-5. doi: 10.1097/PCC.0b013e31818c86e7. No abstract available.

PMID:
18997597
25.

Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms.

van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE.

J Immunol. 2007 Aug 1;179(3):1506-15.

26.

A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes.

van Montfoort N, de Jong JM, Schuurhuis DH, van der Voort EI, Camps MG, Huizinga TW, van Kooten C, Daha MR, Verbeek JS, Ossendorp F, Toes RE.

J Immunol. 2007 Jun 15;178(12):7581-6.

27.

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE.

Eur J Immunol. 2007 Jan;37(1):129-38.

28.

Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.

de Jong JM, Schuurhuis DH, Ioan-Facsinay A, Welling MM, Camps MG, van der Voort EI, Huizinga TW, Ossendorp F, Verbeek JS, Toes RE.

Immunology. 2006 Dec;119(4):499-506. Epub 2006 Sep 21.

29.

Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo.

de Jong JM, Schuurhuis DH, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Ossendorp F, Toes RE, Verbeek JS.

Mol Immunol. 2006 May;43(13):2045-50. Epub 2006 Feb 28.

PMID:
16513171
30.

Characterization of an immuno 'stealth' derivative of the herpes simplex virus thymidine-kinase gene.

Ossevoort M, Zaldumbide A, Cramer SJ, van der Voort EI, Toes RE, Hoeben RC.

Cancer Gene Ther. 2006 Jun;13(6):584-91.

PMID:
16456552
31.

Medical end-of-life decisions for children in the Netherlands.

Vrakking AM, van der Heide A, Arts WF, Pieters R, van der Voort E, Rietjens JA, Onwuteaka-Philipsen BD, van der Maas PJ, van der Wal G.

Arch Pediatr Adolesc Med. 2005 Sep;159(9):802-9.

PMID:
16143738
32.

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Schneider P, Nollau P, Horstmann M, Beverloo HB, van der Voort E, Valsecchi MG, de Lorenzo P, Sallan SE, Armstrong SA, Pieters R.

Blood. 2005 Oct 1;106(7):2484-90. Epub 2005 Jun 14.

PMID:
15956279
33.

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation.

Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM.

Blood. 2005 Apr 1;105(7):2991-4. Epub 2004 Dec 16.

PMID:
15604221
34.

Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.

van Bilsen JH, van Dongen H, Lard LR, van der Voort EI, Elferink DG, Bakker AM, Miltenburg AM, Huizinga TW, de Vries RR, Toes RE.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17180-5. Epub 2004 Nov 29.

35.

Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.

van Mierlo GJ, Boonman ZF, Dumortier HM, den Boer AT, Fransen MF, Nouta J, van der Voort EI, Offringa R, Toes RE, Melief CJ.

J Immunol. 2004 Dec 1;173(11):6753-9.

36.

Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells.

van Duivenvoorde LM, Louis-Plence P, Apparailly F, van der Voort EI, Huizinga TW, Jorgensen C, Toes RE.

Arthritis Rheum. 2004 Oct;50(10):3354-64.

37.

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.

Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, Van Hirtum H, Van Diggelen OP, Boer M, Kroos MA, Van Doorn PA, Van der Voort E, Sibbles B, Van Corven EJ, Brakenhoff JP, Van Hove J, Smeitink JA, de Jong G, Reuser AJ, Van der Ploeg AT.

Pediatrics. 2004 May;113(5):e448-57.

PMID:
15121988
38.

Report of the World Federation of Pediatric Intensive and Critical Care Societies.

van der Voort E, Latour JM, Duncan AW; On behalf of the Executive Board.

Pediatr Crit Care Med. 2004 May;5(3):302-303. No abstract available.

PMID:
19667796
39.

Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.

Ossevoort M, Visser BM, van den Wollenberg DJ, van der Voort EI, Offringa R, Melief CJ, Toes RE, Hoeben RC.

Gene Ther. 2003 Nov;10(24):2020-8.

PMID:
14566361
40.

In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.

Diehl L, van Mierlo GJ, den Boer AT, van der Voort E, Fransen M, van Bostelen L, Krimpenfort P, Melief CJ, Mittler R, Toes RE, Offringa R.

J Immunol. 2002 Apr 15;168(8):3755-62.

41.

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.

van Mierlo GJ, den Boer AT, Medema JP, van der Voort EI, Fransen MF, Offringa R, Melief CJ, Toes RE.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5561-6. Epub 2002 Apr 2.

42.

Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.

Schurmans LR, Diehl L, den Boer AT, Sutmuller RP, Boonman ZF, Medema JP, van der Voort EI, Laman J, Melief CJ, Jager MJ, Toes RE.

J Immunol. 2001 Nov 15;167(10):5832-7.

43.

Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance.

den Boer AT, Diehl L, van Mierlo GJ, van der Voort EI, Fransen MF, Krimpenfort P, Melief CJ, Offringa R, Toes RE.

J Immunol. 2001 Sep 1;167(5):2522-8.

44.

Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.

Sutmuller RP, Schurmans LR, van Duivenvoorde LM, Tine JA, van Der Voort EI, Toes RE, Melief CJ, Jager MJ, Offringa R.

J Immunol. 2000 Dec 15;165(12):7308-15.

45.

The role of CD40 in peripheral T cell tolerance and immunity.

Diehl L, Den Boer AT, van der Voort EI, Melief CJ, Offringa R, Toes RE.

J Mol Med (Berl). 2000;78(7):363-71. Review.

PMID:
11043379
46.

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

Schuurhuis DH, Laban S, Toes RE, Ricciardi-Castagnoli P, Kleijmeer MJ, van der Voort EI, Rea D, Offringa R, Geuze HJ, Melief CJ, Ossendorp F.

J Exp Med. 2000 Jul 3;192(1):145-50.

47.

Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis.

Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL.

Arthritis Rheum. 1999 Nov;42(11):2430-9.

48.

Successful immunotherapy of an intraocular tumor in mice.

Schurmans LR, den Boer AT, Diehl L, van der Voort EI, Kast WM, Melief CJ, Toes RE, Jager MJ.

Cancer Res. 1999 Oct 15;59(20):5250-4.

49.

Cardiovascular aspects of experimental meningococcal sepsis in young and older awake piglets: age-related differences.

Hazelzet JA, Stubenitsky R, Petrov AB, van Wieringen GW, van der Voort E, Hess J, Hop WC, Thijs LG, Duncker DJ, Poolman JT, Verdouw PD.

Shock. 1999 Aug;12(2):145-54.

PMID:
10446896
50.

Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.

Peeters CC, Claassen IJ, Schuller M, Kersten GF, van der Voort EM, Poolman JT.

Vaccine. 1999 Jun 4;17(20-21):2702-12.

PMID:
10418921

Supplemental Content

Loading ...
Support Center